VOV.VN - The prospect of the arrival of fresh vaccine sources to the country until the end of the year is positive, with the aim being to soon have sufficient vaccine coverage for the majority of the population, thereby creating conditions for the process of opening up the national economy.

VOV.VN - Vietnam is starting phases 2 and 3 of its human clinical trial of the ARCT-154 vaccine against COVID-19 following the encouraging results of the first phase.

Vietnam’s GDP is expected to expand by about 4.8% in 2021, and the economy could converge toward the pre-pandemic GDP growth rate of 6.5% to 7% from 2022 onward, the World Bank has forecast.

VOV.VN - Ho Chi Minh City, the epicentre of the country’s prolonged COVID-19 outbreak, is taking drastic actions aimed at curbing the spread of the virus and getting its ailing economy back on track after September 30.

VOV.VN - President Nguyen Xuan Phuc has hailed the role of business associations in the United States for promoting US firms' investment in the Vietnamese market in recent years, during a meeting with business representatives and investors.

Vice President Vo Thi Anh Xuan on September 19 led a delegation to visit the Mekong Delta province of An Giang and present gifts worth close to VND14 billion (US$612,000) to support its fight against the COVID-19 pandemic.

The National Ethics Committee in Biomedical Research under the Ministry of Health on September 19 issued a press statement on its conclusions of a meeting one day earlier during which it looked into the mid-term phase 3 trial’s results of homegrown COVID-19 vaccine Nano Covax.

VOV.VN - Vietnam must devise a range of comprehensive solutions aimed at reviving its COVID ravaged economy in the post pandemic period, according to Nguyen Thi Huong, director of the Vietnam General Statistics Office (GSO).

VOV.VN - T&T PHARMA, a Vietnamese pharmaceutical joint stock company, has inked a contract to purchase 50 million doses of HIPRA, a COVID-19 vaccine produced by Spain’s HYPRA Human Health S.L.U.

Vietnam is likely to remain foreign investors’ favoured destination despite the COVID-19 resurgence ravaging across the country, The Australia Financial Review (ARF) said recently.